Clostridium difficile Infection

On this page

C. diff Pathogenesis - Spore Wars

  • The Culprit: Gram +ve, spore-forming, anaerobic bacillus. Resilient spores drive transmission & relapse. Clostridium difficile bacterium with endospores
  • Spore Lifecycle & Gut Invasion:
    • Ingestion of hardy spores (fecal-oral).
    • Spores survive stomach acid, germinate in colon post-antibiotic dysbiosis.
    • Vegetative cells colonize, multiply, release toxins.
  • Key Virulence Factors - The Toxins: 📌 Toxins ABC
    • Toxin A (TcdA): Enterotoxin ("Aqua" - watery diarrhea). Causes inflammation, fluid secretion.
    • Toxin B (TcdB): Cytotoxin ("Bad" - more potent). Induces severe cytoskeletal damage, cell death.

      ⭐ Toxin B is 10x more potent than Toxin A in causing colonic mucosal damage.

    • Binary Toxin (CDT): ADP-ribosylating toxin ("Complicates"). In hypervirulent strains (e.g., NAP1/BI/027); enhances adherence, ↑ severity.
  • Cellular Sabotage: Toxins A & B glucosylate Rho GTPases → actin disruption, cell death, breaks tight junctions → pseudomembranes.

CDI Clinical & Dx - Gut Check

  • Clinical Spectrum:

    • Asymptomatic carriage to severe, fulminant disease.
    • Common: Watery diarrhea (≥3 loose stools in 24h), abdominal pain, low-grade fever, leukocytosis.
    • Severe: Pseudomembranous colitis, toxic megacolon, colonic perforation, sepsis, shock.
  • Diagnostic Tests (Stool):

    • Glutamate Dehydrogenase (GDH) antigen: Sensitive, not specific (detects C. diff presence).
    • Toxin A/B EIA: Specific, less sensitive (detects toxin production).
    • Nucleic Acid Amplification Test (NAAT/PCR): Highly sensitive & specific for toxigenic C. diff genes (e.g., tcdA, tcdB).
    • Two-step algorithm common: GDH + Toxin EIA. If discordant, proceed to NAAT.
  • Severity Assessment (e.g., IDSA/SHEA criteria for severe CDI):

    • WBC count > 15,000 cells/μL.
    • Serum Creatinine ≥ 1.5 mg/dL or an increase to >1.5x baseline.

Pseudomembranes in C. difficile colitis

⭐ The presence of pseudomembranes on colonoscopy is highly suggestive of CDI, but colonoscopy is not routinely recommended for diagnosis due to perforation risk and availability of non-invasive tests.

CDI Management - Eviction Notice

📌 VFM for initial therapy: Vancomycin, Fidaxomicin, Metronidazole.

  • Initial Episode (Non-Severe):
    • Oral Vancomycin 125 mg QID x 10 days
    • OR Fidaxomicin 200 mg BID x 10 days
    • Metronidazole 500 mg TID x 10-14 days (if Vanco/Fida unavailable).
  • Initial Episode (Severe/Fulminant):
    • Oral Vancomycin 125 mg QID (may ↑ to 500 mg QID if ileus).
    • PLUS IV Metronidazole 500 mg Q8H.
    • Consider rectal vancomycin if ileus.
  • Recurrent CDI:
    • 1st Recurrence:
      • Standard 10-day Oral Vancomycin 125 mg QID, followed by prolonged tapered/pulsed regimen.
      • OR 10-day Fidaxomicin 200 mg BID.
    • 2nd+ Recurrence: (Choose one)
      • Vancomycin taper/pulse regimen.
      • Fidaxomicin 200 mg BID x 10 days (if not used extensively).
      • Fecal Microbiota Transplantation (FMT).
      • Bezlotoxumab (monoclonal antibody vs Toxin B, adjunct to standard antibiotics for prevention of further recurrence).

⭐ Fecal Microbiota Transplantation (FMT) has shown high efficacy (often >80-90%) in treating multiple recurrent CDI.

  • Prevention & Control:
    • Hand hygiene: Soap & water (spores!).
    • Contact precautions: Gloves, gown.
    • Environmental disinfection: Sporicidal agents (e.g., bleach).
    • Antibiotic stewardship.

High‑Yield Points - ⚡ Biggest Takeaways

  • Clostridioides difficile: Gram-positive, anaerobic, spore-forming bacillus causing antibiotic-associated diarrhea (AAD).
  • Key virulence: Toxin A (enterotoxin) & Toxin B (cytotoxin) leading to pseudomembranous colitis.
  • Risk factors: Antibiotic exposure (clindamycin, cephalosporins, fluoroquinolones), hospitalization, PPIs.
  • Diagnosis: Stool NAAT/PCR for toxin genes (most sensitive) or toxin EIA.
  • Treatment: Oral vancomycin or fidaxomicin. Metronidazole for mild, initial non-severe episodes.
  • Prevention: Soap & water hand hygiene (spores resist alcohol), contact precautions, antibiotic stewardship.
  • High recurrence rates; consider Fecal Microbiota Transplantation (FMT) for multiple refractory recurrences.

Practice Questions: Clostridium difficile Infection

Test your understanding with these related questions

A 40-year old woman presented to the surgical OPD with features suggestive of colitis. She was on prolonged treatment with clindamycin. Fecal sample was positive for toxin produced by this agent. Her condition improved on treatment with metronidazole. The clinical condition is associated with -

1 of 5

Flashcards: Clostridium difficile Infection

1/8

Hospital acquired MRSA is mediated by mecA subtype _____

TAP TO REVEAL ANSWER

Hospital acquired MRSA is mediated by mecA subtype _____

I, II, III

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial